Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection
The Medical News,
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative virus of coronavirus disease 2019 (COVID19)..
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection
Overview of attention for article published in medRxiv, December 2021
Altmetric Badge
Readers on
- mendeley
- 15 Mendeley